Abstract:Cancer phototheranostics, composed of optical diagnosis and phototherapy (including photodynamic therapy and photothermal therapy), is a promising strategy for precise tumor treatment. Due to the unique properties of near-infrared absorption/emission, high reactive oxygen species generation, and photothermal conversion efficiency, aza-boron-dipyrromethene (aza-BODIPY), as an emerging organic photosensitizer, has shown great potential for tumor phototheranostics. By encapsulating aza-BODIPY photosensitizers within functional amphiphilic polymers, we can afford hydrophilic nanomedicines that selectively target tumor sites via an enhanced permeability and retention effect, thereby efficiently improving diagnosis and therapeutic efficacy. Herein, in this spotlight article, we attempt to highlight our recent contributions in the development of aza-BODIPY-based nanomedicines, which comprises three main sections: (1) to elucidate the design strategy of aza-BODIPY photosensitizers and corresponding nanomedicines; (2) to overview their photophysical properties and biomedical applications in phototheranostics, including fluorescence imaging, photoacoustic imaging, photodynamic therapy, photothermal therapy, and synergistic therapy; and (3) to depict the challenges and future perspectives of aza-BODIPY nanomedicines. It is believed that this Spotlight on Applications article would illuminate the way of developing new aza-BODIPY nanomedicines as well as other organic photosensitizer-based nanomedicines for future clinical translation.

Azobenzene Photoswitch for Isomerization‐Dependent Cancer Therapy via Azo‐Combretastatin A4 and Phototrexate

Triggered Azobenzene-Based Prodrugs and Drug Delivery Systems.

A Rationally Designed Azobenzene Photoswitch for DNA G‐Quadruplex Regulation in Live Cells

Photo-triggered Micelles: Simultaneous Activation and Release of Microtubule Inhibitors for On-Demand Chemotherapy

Hypoxia-induced Activity Loss of a Photo-Responsive Microtubule Inhibitor Azobenzene Combretastatin A4

131I Induced in Vivo Proteolysis by Photoswitchable Azoprotac Reinforces Internal Radiotherapy

A Photoisomerizable Zinc (II) Complex Inhibits Microtubule Polymerization for Photoactive Therapy

Photoactivatable Dihydroalkaloids for Cancer Cell Imaging and Chemotherapy with High Spatiotemporal Resolution

Aza-BODIPY-Based Nanomedicines in Cancer Phototheranostics.

A Promising Strategy for Synergistic Cancer Therapy by Integrating a Photosensitizer into a Hypoxia-Activated Prodrug.

Photoactivatable Dihydroalkaloids for Cancer Theranostics with AIE Characteristics

Design, Synthesis, and Bioevaluation of Novel Reversibly Photoswitchable PI3K Inhibitors Based on Phenylazopyridine Derivatives toward Light-Controlled Cancer Treatment

Azobispyrazole Family As Photoswitches Combining (Near-) Quantitative Bidirectional Isomerization and Widely Tunable Thermal Half-Lives from Hours to Years*.

Azobenzene-based liposomes with nanomechanical action for cytosolic chemotherapeutic drug delivery

Arylazobenzimidazoles: Versatile Visible-Light Photoswitches with Tuneable Z-isomer Stability

Activatable Phototherapeutic Prodrug Conquering Hypoxia Limitation to Enhance Chemical Drug Delivery Efficiency

Reconstructing Tumor Microenvironment Using Photoresponsive Cyanobacteria to Reversal Chemoresistance for Robust Chemotherapy

New tricks and emerging applications from contemporary azobenzene research

Discovery of a Novel Photoswitchable PI3K Inhibitor Toward Optically-Controlled Anticancer Activity.

Recent Advances of Light/Hypoxia‐Responsive Azobenzene in Nanomedicine Design

Light Switchable Ir(III)-Based Photosensitizers: A Dual-State System for Non-Invasive, Reversible ROS Control in Tumor Therapy